Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
TXT Textron Inc
INSG Inseego Corp
AVDL Avadel Pharmaceuticals PLC
LCSHY Lancashire Holdings Ltd
NET Cloudflare Inc
PRCT PROCEPT BioRobotics Corp
AAL American Airlines Group Inc
ATXS Astria Therapeutics Inc
FRGT Freight Technologies Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, and Stribild. The Company’s COVID-19 product is Veklury. The Company’s also provides Epclusa, Harvoni, Vemlidy, and Viread products for liver diseases. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The Company’s other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.

Postmarket

Last Trade
Delayed
$81.25
-0.20 (-0.25%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$81.45
Day's Change
0.16 (0.20%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
81.90
Day's Low
81.06
Volume
(Light)
Volume:
3,807,361

10-day average volume:
6,232,151
3,807,361
  • Prev Close
    81.29
  • Today's Open
    81.78
  • Day's Range
    81.06-81.90
  • Avg Vol (10-day)
    6.2M
  • Last (time)
    4:00p ET 03/30/23
  • Last (size)
    10
  • 52-Wk Range
    57.17 - 89.74
    LowHigh
  • (06/14/22 - 12/13/22)
    9.24%
  • 25.7%
  • Market Cap
    101.7B
  • Shares Outstanding
    1.2B
  • 3.64
  • 22.34x
  • $3.00/3.69%
  • Ex-dividend Date
    03/14/23
  • Dividend Pay Date
    03/30/23
  • 0.4
  • 83.47
  • (% of float 02/28/23)
    1.26

Latest News

March 30, 2023
4:56 pm ET
MarketWatch
March 29, 2023
4:57 pm ET
MarketWatch
March 28, 2023
4:57 pm ET
MarketWatch
4:50 pm ET
Zacks
March 27, 2023
4:56 pm ET
MarketWatch
March 24, 2023
4:56 pm ET
MarketWatch
March 23, 2023
4:57 pm ET
MarketWatch
6:30 am ET
BusinessWire
March 22, 2023
4:57 pm ET
MarketWatch
12:00 pm ET
BusinessWire
March 21, 2023
4:57 pm ET
MarketWatch
9:37 am ET
BusinessWire
March 20, 2023
4:57 pm ET
MarketWatch
12:56 pm ET
MarketWatch
9:01 am ET
MarketWatch
8:30 am ET
Globe Newswire
8:30 am ET
BusinessWire
March 17, 2023
4:57 pm ET
MarketWatch
March 16, 2023
4:57 pm ET
MarketWatch
March 15, 2023
4:57 pm ET
MarketWatch
March 13, 2023
4:57 pm ET
MarketWatch
March 10, 2023
4:57 pm ET
MarketWatch
March 09, 2023
4:57 pm ET
MarketWatch
March 08, 2023
4:57 pm ET
MarketWatch
March 07, 2023
4:57 pm ET
MarketWatch
March 06, 2023
4:57 pm ET
MarketWatch
March 03, 2023
4:57 pm ET
MarketWatch
March 02, 2023
4:56 pm ET
MarketWatch
March 01, 2023
4:57 pm ET
MarketWatch
February 28, 2023
4:59 pm ET
MarketWatch
February 27, 2023
4:56 pm ET
MarketWatch
February 24, 2023
4:57 pm ET
MarketWatch
1:41 pm ET
MarketWatch
February 23, 2023
4:56 pm ET
MarketWatch
February 22, 2023
4:57 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.